An animal feed additive composition comprises an effective amount of a laidlomycin, a carrier, magnesium sulfate, and silicon dioxide. Other embodiments include methods of making the animal feed additive compositions, and the use of a laidlomycin in the manufacture of an animal feed additive for increasing the efficiency of feed utilization and rate of weight gain in domestic animals.
A61K 31/35 - Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
2.
BACTERIOPHAGE PREPARATIONS AND METHOD OF USE THEREOF
Disclosed herein are purified bacteriophage preparations that effectively lyse a plurality of C. perfringens strains. In one embodiment, a purified bacteriophage preparation includes four or more C. perfringens-specific bacteriophage, wherein each bacteriophage has lytic activity against at least five C. perfringens strains. In another embodiment, the purified bacteriophage preparation includes five or more C. perfringens-specific bacteriophage.
Provided herein is a pharmaceutical composition comprising an antagonist, an agonist, a seal coat, and a sequestering polymer, wherein the antagonist, agonist, seal coat and at least one sequestering polymer are all components of a single unit, and wherein the seal coat forms a layer physically separating the antagonist from the agonist from one another. Methods for manufacturing such a pharmaceutical composition are also provided.
Disclosed is a multiparticulate in-feed additive composition comprising praziquantel or a salt thereof and cimetidine or a salt thereof, a medicated fish-feed comprising the multiparticulate in-feed additive composition, and a method of eliminating or reducing or preventing parasites in a fish population.
Disclosed is a multiparticulate in- feed additive composition comprising Emamectin or a salt thereof, a method of manufacturing the multiparticulate in- feed additive composition, a medicated fish- feed comprising the multiparticulate in- feed additive composition, and a method of eliminating or reducing or preventing parasites in a fish population.
An animal feed additive composition comprises an effective amount of a maduramicin ammonium, a carrier, a binder, and optionally a pH regulator. Other embodiments include methods of making the animal feed additive compositions, and the use of a maduramicin in the manufacture of an animal feed additive for treating coccidiosis.
Disclosed herein are tetracycline medicated feed premixes and methods for the stabilization thereof. In one embodiment, a medicated feed premix comprises 15 wt% to 65 wt% of a pharmaceutically acceptable chlortetracycline hydrochloride, 20 wt% to 85 wt% of a carrier, and 0.1 wt% to 10 wt% of a binder, wherein all amounts are based on the total weight of the animal feed supplement. Also included are methods of making a medicated feed premix, the use of a chlortetracycline hydrochloride in the manufacture of a medicament for treating microbial infections in animals, and an animal feed composition.
Provided herein is a method of treating a condition in a host that is responsive to an agonist, the method comprising administering to the host a multi-layer pharmaceutical composition comprising the agonist eg. an opioid and an antagonist eg. naltrexone thereof, wherein the agonist and antagonist are not in direct contact with one another in the intact form of the composition.
Provided herein is a pharmaceutical composition comprising an antagonist, an agonist, a seal coat, and a sequestering polymer, wherein the antagonist, agonist, seal coat and at least one sequestering polymer are all components of a single unit, and wherein the seal coat forms a layer physically separating the antagonist from the agonist from one another. Methods for manufacturing. such a pharmaceutical composition are also provided.
patents
